Alzheimer's disease—the most common form of dementia—is a progressive neurological disorder that causes brain cells to ...

New recommendations to help healthcare providers explain amyloid therapies to Alzheimer’s patients and their caregivers involve sharing the benefits and risks of the medications.

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Our Director of Research Dr Sheona Scales describes her four highlights from this year's Clinical Trials on Alzheimer's ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

As we recognize Alzheimer’s Awareness Month in November, it’s a timely reminder to consider how we can protect and support ...

Researchers at Case Western Reserve school of Medicine looked at nearly one million patients in the U.S. with Type 2 diabetes ...

New St Vincent Institute research has found the treatment of Alzheimer’s disease will take more than a “magic bullet”.

November is Alzheimer’s Awareness Month. “The disease touches everybody in the patient’s world,” said Dr. Linnea Pepper. Alzheimer’s is a disease that knows no stranger. “It’s actually the seventh ...

"We could either stop the disease before it starts which is the silver bullet ... For so long, we had a drought when it came ...